Using <scp>l</scp>‐Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis

Abstract

The compiled evidence suggests there are several potential explanations for the variability in carnitine concentrations and clinical response to l-carnitine in septic shock. These serve as important confounders that should be considered in interpretation of l-carnitine clinical studies and broadly holds lessons for future clinical trial design in sepsis. Consideration of these factors is needed if precision medicine in sepsis is to be achieved.